Crossmark

Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors

Crossref DOI link: https://doi.org/10.1007/s10067-018-4105-3

Published Online: 2018-04-18

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tymms, Kathleen

Littlejohn, Geoff

Griffiths, Hedley

de Jager, Julien

Bird, Paul

Joshua, Fred

Nash, Peter

Handel, Malcolm

McManus, Hamish

Butcher, Belinda E.

Youssef, Peter
Funding

Funding for this research was provided by:

Janssen-Cilag Pty Ltd (N/A)
License Information

Text and Data Mining valid from 2018-04-18
More Information

Article History

Received: 18 December 2017

Revised: 7 March 2018

Accepted: 10 April 2018

First Online: 18 April 2018

Compliance with ethical standards

:

: BB is an independent statistician and medical writer who has consulted to a wide number of pharmaceutical companies, including AbbVie, Janssen-Cilag Pty Ltd., and Roche Products Ltd.

Document is current

Any future updates will be listed below